Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection

Infection and Immunity

Volumn 74, Issue 10, 2006, Pages 5513-5521

  Imtiaz, Muhammad T ^a   Schripsema, Justin H ^a   Sigar, Ira M ^a   Kasimos, John N ^a   Ramsey, Kyle H ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; CAPTOPRIL; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE MARKER; DISEASE MODEL; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; HYDROSALPINX; INFECTION PREVENTION; INFECTION SENSITIVITY; INFERTILITY; KINETICS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; UROGENITAL TRACT INFECTION; UTERINE TUBE OCCLUSION;

ANIMALS; CAPTOPRIL; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHRONIC DISEASE; FEMALE; FEMALE UROGENITAL DISEASES; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASES; MICE; MICE, MUTANT STRAINS; OLIGOPEPTIDES; TETRACYCLINE;

EID: 33749250965     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00730-06     Document Type: Article

References (45)

1. Abu el-Asrar, A. M., K. Geboes, S. A. Al Kharashi, A. A. Al Mosallam, L. Missotten, L. Paemen, and G. Opdenakker. 2000. Expression of gelatinase B in trachomatous conjunctivitis. Br. J. Ophthalmol. 84:85-91.
2. Abu el-Asrar, A. M., K. Geboes, and L. Missotten. 2001. Immunology of trachomatous conjunctivitis. Bull. Soc. Belge Ophtalmol. 280:73-96.
3. Ault, K. A., K. A. Kelly, P. E. Ruther, I. M. Sigar, and K. H. Ramsey. 2002. Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube. Am. J. Obstet. Gynecol. 187:1377-1383.
4. Balakrishnan, A., B. Patel, S. A. Sieber, D. Chen, N. Pachikara, G. Zhong, B. F. Cravatt, and H. Fan. 2006. Metalloprotease inhibitors GM6001 and TAP1-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium. J. Biol. Chem. 281:16691-16699. (First published 24 March 2006; doi:10.1074/jbc.M513648200.)
5. Chantrain, C. F., P. Henriet, S. Jodele, H. Emonard, O. Feron, P. J. Courtoy, Y. A. DeClerck, and E. Marbaix. 2006. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. Eur. J. Cancer 42:310-318.
6. Clark, R. A., and W. M. Nauseef. 1996. Isolation and functional analysis of neutrophils, p. 7.23.8-7.23.10. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
7. Cotter, T. W., K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen, and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65:2145-2152.
8. Darville, T., C. W. Andrews, Jr., K. K. Laffoon, W. Shymasani, L. R. Kishen, and R. G. Rank. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65:3065-3073.
9. de la Maza, L. M., S. Pal, A. Khamesipour, and E. M. Peterson. 1994. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect. Immun. 62:2094-2097.
10. Descamps, F. J., P. E. Van den Steen, I. Nelissen, J. Van Damme, and G. Opdenakker. 2003. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes. Adv. Exp. Med. Biol. 535:69-77.
11. Dollery, C. M., and P. Libby. 2006. Atherosclerosis and proteinase activation. Cardiovasc. Res. 69:625-635.
12. Greenwald, R. A., and L. M. Golub. 2006. Biologic properties of non-antibiotic, chemically modified tetracyclines (CMTs): a structured, annotated bibliography. Curr. Med. Chem. 8:237-242.
13. Maeda, H., T. Okamoto, and T. Akaike. 1998. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol. Chem. 379:193-200.
14. Maitra, S. R., M. J. Shapiro, S. Bhaduri, and M. R. El Maghrabi. 2005. Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats. Crit. Care Med. 33:1577-1581.
15. Mezzano, S. A., M. Ruiz-Ortega, and J. Egido. 2001. Angiotensin II and renal fibrosis. Hypertension 38:635-638.
16. Migdalof, B. H., M. J. Antonaccio, D. N. McKinstry, S. M. Singhvi, S. J. Lan, P. Egli, and K. J. Kripalani. 1984. Captopril: pharmacology, metabolism and disposition. Drug Metab. Rev. 15:841-869.
17. Murphy, G., and J. Gavrilovic. 1999. Proteolysis and cell migration: creating a path? Curr. Opin. Cell Biol. 11:614-621.
18. Nagase, H., and J. F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491-21494.
19. Opdenakker, G., P. E. Van den Steen, B. Dubois, I. Nelissen, E. Van Coillie, S. Masure, P. Proost, and J. Van Damme. 2001. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69:851-859.
20. Pal, S., A. P. Schmidt, E. M. Peterson, C. L. Wilson, and L. M. De La Maza. 2006. Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection. Immunology 117:213-219.
21. Patton, D. L., D. V. Landers, and J. Schachter. 1989. Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection. J. Infect. Dis. 159:1105-1110.
22. Ramsey, K. H., T. W. Cotter, R. D. Salyer, G. S. Miranpuri, M. A. Yanez, C. E. Poulsen, J. L. DeWolfe, and G. I. Byrne. 1999. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect. Immun. 67:3019-3025.
23. Ramsey, K. H., I. M. Sigar, S. V. Rana, J. Gupta, S. M. Holland, and G. I. Byrne. 2001. Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect. Immun. 69:7374-7379.
24. Ramsey, K. H., I. M. Sigar, J. H. Schripsema, N. Shaba, and K. P. Cohoon. 2005. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect. Immun. 73:6962-6973.
25. Rank, R. G. 1999. Models of immunity, p. 239-295. In R. S. Stephens (ed.), Chlamydia: intracellular biology, pathogenesis, and immunity. American Society for Microbiology, Washington, D.C.
26. Rank, R. G., M. M. Sanders, and D. L. Patton. 1995. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex. Transm. Dis. 22:48-54.
27. Register, K. B., P. A. Morgan, and P. B. Wyrick. 1986. Interaction between Chlamydia spp. and human polymorphonuclear leukocytes in vitro. Infect. Immun. 52:664-670.
28. Ruiz-Ortega, M., and J. Egido. 1997. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 52:1497-1510.
29. Sapadin, A. N., and R. Fleischmajer. 2006. Tetracyclines: nonantibiotic properties and their clinical implications. J. Am. Acad. Dermatol. 54:258-265.
30. Shah, A. A., J. H. Schripsema, M. T. Imtiaz, I. M. Sigar, J. Kasimos, P. G. Matos, S. Inouye, and K. H. Ramsey. 2005. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex. Transm. Dis. 32:49-56.
31. Singhvi, S. M., K. J. Kripalani, A. V. Dean, G. R. Keim, J. S. Kulesza, F. S. Meeker, J. J. Ross, J. M. Shaw, and B. H. Migdalof. 1981. Absorption and bioavailability of captopril in mice and rats after administration by gavage and in the diet. J. Pharm. Sci. 70:885-888.
32. Soloff, B. L., R. G. Rank, and A. L. Barron. 1985. Electron microscopic observations concerning the in vivo uptake and release of the agent of guinea-pig inclusion conjunctivitis (Chlamydia psittaci) in guinea-pig exocervix. J. Comp. Pathol. 95:335-344.
33. Sorbi, D., M. Fadly, R. Hicks, S. Alexander, and L. Arbeit. 1993. Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int. 44:1266-1272.
34. Su, H., R. Messer, W. Whitmire, E. Fischer, J. C. Portis, and H. D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J. Exp. Med. 188:809-818.
35. Su, H., R. Messer, W. Whitmire, S. Hughes, and H. D. Caldwell. 2000. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infect. Immun. 68:192-196.
36. Su, H., R. Morrison, R. Messer, W. Whitmire, S. Hughes, and H. D. Caldwell. 1999. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J. Infect. Dis. 180:1252-1258.
37. Suchland, R. J., W. M. Geisler, and W. E. Stamm. 2003. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob. Agents Chemother. 47:636-642.
38. Swenson, C. E., E. Donegan, and J. Schachter. 1983. Chlamydia trachomatis-induced salpingitis in mice. J. Infect. Dis. 148:1101-1107.
39. Swenson, C. E., M. L. Sung, and J. Schachter. 1986. The effect of tetracycline treatment on chlamydial salpingitis and subsequent fertility in the mouse. Sex. Transm. Dis. 13:40-44.
40. Vaday, G. G., S. Franitza, H. Schor, I. Hecht, A. Brill, L. Cahalon, R. Hershkoviz, and O. Lider. 2001. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J. Leukoc. Biol. 69:885-892.
41. Vaday, G. G., R. Hershkoviz, M. A. Rahat, N. Lahat, L. Cahalon, and O. Lider. 2000. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis. J. Leukoc. Biol. 68:737-747.
42. Van den Steen, P. E., S. J. Husson, P. Proost, J. Van Damme, and G. Opdenakker. 2003. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem. Biophys. Res. Commun. 310:889-896.
43. Van den Steen, P. E., G. Opdenakker, M. R. Wormald, R. A. Dwek, and P. M. Rudd. 2001. Matrix remodelling enzymes, the protease cascade and glycosylation. Biochim. Biophys. Acta 1528:61-73.
44. Visse, R., and H. Nagase. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827-839.
45. Volpert, O. V., W. F. Ward, M. W. Lingen, L. Chesler, D. B. Solt, M. D. Johnson, A. Molteni, P. J. Polverini, and N. P. Bouck. 1996. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Investig. 98:671-679.